Distinct mechanisms for diastolic dysfunction in diabetes mellitus and chronic pressure-overload

被引:50
作者
Falcao-Pires, Ines [1 ]
Palladini, Giuseppina [2 ]
Goncalves, Nadia [1 ]
van der Velden, Jolanda [3 ]
Moreira-Goncalves, Daniel [1 ]
Miranda-Silva, Daniela [1 ]
Salinaro, Francesco [2 ]
Paulus, Walter J. [3 ]
Niessen, Hans W. M. [4 ]
Perlini, Stefano [2 ]
Leite-Moreira, Adelino F. [1 ]
机构
[1] Univ Porto, Fac Med, Dept Physiol & Cardiothorac Surg, Cardiovasc R&D Unit, P-4200319 Oporto, Portugal
[2] Univ Pavia, Fdn IRCCS San Matteo, I-27100 Pavia, Italy
[3] Vrije Univ Med Ctr Amsterdam, Dept Physiol, Inst Cardiovasc Res, Amsterdam, Netherlands
[4] Vrije Univ Med Ctr, Amsterdam, Netherlands
关键词
Diabetes mellitus; Diastolic function; Hypertrophy; Myocardial stiffness; Pressure-overload; Relaxation; BINDING PROTEIN-C; LIGHT-CHAIN PHOSPHORYLATION; HEART-FAILURE; CARDIAC-FUNCTION; MATRIX METALLOPROTEINASES; VENTRICULAR FUNCTION; FAILING HEART; END-PRODUCTS; RATS; HYPERTROPHY;
D O I
10.1007/s00395-011-0184-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic pressure-overload and diabetes mellitus are two frequent disorders affecting the heart. We aimed to characterize myocardial structural and functional changes induced by both conditions. Pressure-overload was established in Wistar-han male rats by supra-renal aortic banding. Six-weeks later, diabetes was induced by streptozotocin (65 mg/kg,ip), resulting in four groups: SHAM, banding (BA), diabetic (DM) and diabetic-banding (DB). Six-weeks later, pressure-volume loops were obtained and left ventricular samples were collected to evaluate alterations in insulin signalling pathways, extracellular matrix as well as myofilament function and phosphorylation. Pressure-overload increased cardiomyocyte diameter (BA 22.0 +/- A 0.4 mu m, SHAM 18.2 +/- A 0.3 mu m) and myofilament maximal force (BA 25.7 +/- A 3.6 kN/m(2), SHAM 18.6 +/- A 1.4 kN/m(2)), Ca2+ sensitivity (BA 5.56 +/- A 0.02, SHAM 5.50 +/- A 0.02) as well as MyBP-C, Akt and Erk phosphorylation, while decreasing rate of force redevelopment (K (tr); BA 14.9 +/- A 1.1 s(-1), SHAM 25.2 +/- A 1.5 s(-1)). At the extracellular matrix level, fibrosis (BA 10.8 +/- A 0.9%, SHAM 5.3 +/- A 0.6%), pro-MMP-2 and MMP-9 activities increased and, in vivo, relaxation was impaired (tau; BA 14.0 +/- A 0.9 ms, SHAM 12.9 +/- A 0.4 ms). Diabetes increased cardiomyocyte diameter, fibrosis (DM 21.4 +/- A 0.4 mu m, 13.9 +/- A 1.8%, DB 20.6 +/- A 0.4 mu m, 13.8 +/- A 0.8%, respectively), myofilament Ca(2+)sensitivity (DM 5.57 +/- A 0.02, DB 5.57 +/- A 0.01), advanced glycation end-product deposition (DM 4.9 +/- A 0.6 score/mm(2), DB 5.1 +/- A 0.4 score/mm(2), SHAM 2.1 +/- A 0.3 score/mm(2)), and apoptosis, while decreasing K (tr) (DM 13.5 +/- A 1.9 s(-1), DB 15.2 +/- A 1.4 s(-1)), Akt phosphorylation and MMP-9/TIMP-1 and MMP-1/TIMP-1 ratios. Diabetic hearts were stiffer (higher end-diastolic-pressure: DM 7.0 +/- A 1.2 mmHg, DB 6.7 +/- A 0.7 mmHg, SHAM 5.3 +/- A 0.4 mmHg, steeper end-diastolic-pressure-volume relation: DM 0.59 +/- A 0.18, DB 0.83 +/- A 0.17, SHAM 0.41 +/- A 0.10), and hypo-contractile (decreased end-systolic-pressure-volume-relation). DB animals presented further pulmonary congestion (Lungs/body-weight: DB 5.23 +/- A 0.21 g/kg, SHAM 3.80 +/- A 0.14 g/kg) as this group combined overload-induced relaxation abnormalities and diabetes-induced stiffness. Diabetes mellitus and pressure overload led to distinct diastolic dysfunction phenotypes: while diabetes promoted myocardial stiffening, pressure overload impaired relaxation. The association of these damages accelerates the progression of diastolic heart failure progression in diabetic-banded animals.
引用
收藏
页码:801 / 814
页数:14
相关论文
共 52 条
[21]   PICROSIRIUS STAINING PLUS POLARIZATION MICROSCOPY, A SPECIFIC METHOD FOR COLLAGEN DETECTION IN TISSUE-SECTIONS [J].
JUNQUEIRA, LCU ;
BIGNOLAS, G ;
BRENTANI, RR .
HISTOCHEMICAL JOURNAL, 1979, 11 (04) :447-455
[22]   TNFα in atherosclerosis, myocardial ischemia/reperfusion and heart failure [J].
Kleinbongard, Petra ;
Heusch, Gerd ;
Schulz, Rainer .
PHARMACOLOGY & THERAPEUTICS, 2010, 127 (03) :295-314
[23]   Heart failure - Current perspectives in diastolic dysfunction and diastolic heart failure [J].
Leite-Moreira, AF .
HEART, 2006, 92 (05) :712-718
[24]   The roles of MMP-2/TIMP-2 in extracellular matrix remodelling in the hearts of STZ-induced diabetic rats [J].
Li, Qian ;
Sun, Shu-zhen ;
Wang, Yi ;
Tian, Yong-jie ;
Liu, Ming-hua .
ACTA CARDIOLOGICA, 2007, 62 (05) :485-491
[25]   ABNORMAL CARDIAC-FUNCTION IN THE STREPTOZOTOCIN-DIABETIC RAT - CHANGES IN ACTIVE AND PASSIVE PROPERTIES OF THE LEFT-VENTRICLE [J].
LITWIN, SE ;
RAYA, TE ;
ANDERSON, PG ;
DAUGHERTY, S ;
GOLDMAN, S .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (02) :481-488
[26]   Changes in cardiac contractility related to calcium-mediated changes in phosphorylation of myosin-binding protein C [J].
McClellan, G ;
Kulikovskaya, I ;
Winegrad, S .
BIOPHYSICAL JOURNAL, 2001, 81 (02) :1083-1092
[27]   Differential effects of pressure or volume overload on myocardial MMP levels and inhibitory control [J].
Nagatomo, Y ;
Carabello, BA ;
Coker, ML ;
McDermott, PJ ;
Nemoto, S ;
Hamawaki, M ;
Spinale, FG .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 278 (01) :H151-H161
[28]   Sympathectomy or doxazosin, but not propranolol, blunt myocardial interstitial fibrosis in pressure-overload hypertrophy [J].
Perlini, S ;
Palladini, G ;
Ferrero, I ;
Tozzi, R ;
Fallarini, S ;
Facoetti, A ;
Nano, R ;
Clari, F ;
Busca, G ;
Fogari, R ;
Ferrari, AU .
HYPERTENSION, 2005, 46 (05) :1213-1218
[29]   Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression [J].
Polyakova, V ;
Hein, S ;
Kostin, S ;
Ziegelhoeffer, T ;
Schaper, J .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (08) :1609-1618
[30]   Diabetic cardiomyopathy - The search for a unifying hypothesis [J].
Poornima, IG ;
Parikh, P ;
Shannon, RP .
CIRCULATION RESEARCH, 2006, 98 (05) :596-605